- Home
- JAZZ vs AMKR Comparison
JAZZ vs AMKR Comparison
Compare JAZZ & AMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- AMKR
- Stock Information
- Founded
- JAZZ 2003
- AMKR 1968
- Country
- JAZZ Ireland
- AMKR United States
- Employees
- JAZZ N/A
- AMKR N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- AMKR Semiconductors
- Sector
- JAZZ Health Care
- AMKR Technology
- Exchange
- JAZZ Nasdaq
- AMKR Nasdaq
- Market Cap
- JAZZ 6.7B
- AMKR 6.1B
- IPO Year
- JAZZ 2007
- AMKR 1998
- Fundamental
- Price
- JAZZ $107.51
- AMKR $20.16
- Analyst Decision
- JAZZ Strong Buy
- AMKR Buy
- Analyst Count
- JAZZ 12
- AMKR 7
- Target Price
- JAZZ $183.08
- AMKR $26.67
- AVG Volume (30 Days)
- JAZZ 730.8K
- AMKR 1.7M
- Earning Date
- JAZZ 07-30-2025
- AMKR 07-28-2025
- Dividend Yield
- JAZZ N/A
- AMKR 3.65%
- EPS Growth
- JAZZ 49.21
- AMKR N/A
- EPS
- JAZZ 7.51
- AMKR 1.28
- Revenue
- JAZZ $4,064,808,000.00
- AMKR $6,273,756,000.00
- Revenue This Year
- JAZZ $6.05
- AMKR $1.27
- Revenue Next Year
- JAZZ $4.68
- AMKR $6.39
- P/E Ratio
- JAZZ $14.35
- AMKR $15.67
- Revenue Growth
- JAZZ 5.76
- AMKR N/A
- 52 Week Low
- JAZZ $95.49
- AMKR $14.03
- 52 Week High
- JAZZ $148.06
- AMKR $44.86
- Technical
- Relative Strength Index (RSI)
- JAZZ 45.65
- AMKR 58.35
- Support Level
- JAZZ $106.56
- AMKR $19.82
- Resistance Level
- JAZZ $109.43
- AMKR $20.75
- Average True Range (ATR)
- JAZZ 2.66
- AMKR 0.57
- MACD
- JAZZ -0.16
- AMKR 0.06
- Stochastic Oscillator
- JAZZ 12.27
- AMKR 79.93
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About AMKR Amkor Technology Inc.
Amkor Technology Inc is a provider of outsourced semiconductor packaging and test services to integrated device manufacturers, fabless semiconductor companies, and contract foundries. The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.